Rexahn Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial ... Wall Street Journal The trial is a multi-center study designed to evaluate the efficacy of Archexin in combination with everolimus (Afinitor(R)) to treat metastatic RCC patients and will be conducted in two stages. The first stage will be dose ranging, with up to three ... |
